The correlation between high SFRP1 expression with patients’ survival was diverse and was correlated with poor prognoses in bladder carcinoma, kidney renal papillary cell carcinoma, lung squamous cell carcinoma, ovarian cancer, and rectal and stomach adenocarcinoma (Fig. 2). This evidence concerns the gene SFRP1 and urinary bladder carcinoma.